How Do I Report Adverse Events in Europe?

Adverse event reporting in Europe requires manufacturers to notify competent authorities when medical devices or IVDs cause harm, malfunction, or pose safety risks. You must report through EUDAMED within specific timeframes ranging from immediately to 30 days, depending on severity. The process involves submitting detailed incident information, device details, and corrective actions taken.

What Exactly Counts As An Adverse Event In European Medical Device Regulations?

An adverse event in European medical device regulations encompasses several categories of incidents that require careful identification and assessment:

• Device malfunctions causing harm: Any failure in device performance that leads to death, serious injury, or poses a threat to patient safety, including situations where the device fails to perform as intended
• Labeling-related incidents: Situations where inadequate instructions, warnings, or contraindications contribute to harmful outcomes or inappropriate device use
• IVD-specific events: False results leading to inappropriate medical decisions, software errors affecting test accuracy, and contamination issues that compromise patient safety
• Near-miss incidents: Situations where serious harm was narrowly avoided, providing valuable insights for preventing future occurrences
• Contributory incidents: Any death or serious injury to which a device may have contributed, requiring investigation even when the device’s involvement is not immediately clear

Understanding these categories helps manufacturers establish comprehensive surveillance systems that capture all reportable events while distinguishing them from routine product complaints or expected device limitations. This systematic approach ensures compliance with European reporting requirements while supporting continuous safety improvement.

It is important to distinguish adverse events from other safety concerns. Product complaints without patient impact, minor device defects that do not affect safety, and expected side effects clearly described in the labeling typically do not require formal adverse event reports. However, manufacturers should maintain records of all safety-related feedback to identify potential trends that might warrant reporting.

When Do You Need To Report Adverse Events To European Authorities?

European adverse event reporting operates on strict timelines that vary based on incident severity and potential public health impact:

• Immediate notification: Deaths and serious injuries require immediate notification to competent authorities, with formal reports due within 15 days of becoming aware of the incident
• Standard reporting: Less severe events must be reported within 30 days, allowing time for preliminary investigation and data collection
• Trend reporting: Multiple similar incidents require consolidated reports every 90 days or upon specific request from competent authorities
• Public health threats: Serious safety concerns affecting multiple patients may require notification within 24 hours, demanding rapid response capabilities
• Follow-up obligations: Updated information must be provided within 30 days if new details emerge, with final reports typically due within 90 days

These timelines create a structured approach to safety communication that balances the need for rapid notification with thorough investigation. The reporting clock starts from the moment of awareness, not investigation completion, making robust internal systems essential for compliance.

Follow-up obligations continue after initial reporting. You must provide updated information within 30 days if new details emerge during your investigation. Additionally, final reports documenting root causes, corrective actions, and preventive measures are typically due within 90 days of the initial report, although competent authorities may request specific timelines based on incident severity.

How Do You Actually Submit Adverse Event Reports Through EUDAMED?

Successfully navigating EUDAMED requires systematic preparation and understanding of the platform’s requirements:

• Account setup and verification: Create an EUDAMED account through the Actor Registration module, providing SRN (Single Registration Number) and In-Country Representative information for identity verification
• System navigation: Access the Vigilance and Post-Market Surveillance section after registration, selecting appropriate report types based on incident severity and device classification
• Mandatory field completion: Submit device identification details including UDI, comprehensive incident descriptions, available patient information, and preliminary assessments of device involvement
• Documentation requirements: Provide incident timelines, clinical information, device history, investigation plans, risk assessments, and implemented corrective actions
• Quality assurance measures: Utilize standardized templates, maintain updated device databases, and establish clear internal workflows for rapid information gathering

This structured approach to EUDAMED submission ensures completeness while minimizing delays that could impact patient safety communication. Regular system testing and staff training prevent technical issues during critical reporting situations, supporting consistent compliance across all incident types.

What Happens After You Submit An Adverse Event Report In Europe?

The post-submission process involves comprehensive regulatory review and ongoing manufacturer obligations:

• Authority review process: Competent authorities evaluate reports within 60 days, assessing incident severity, device involvement, investigation quality, and proposed preventive measures
• Information requests: Authorities may require additional clinical data, technical clarifications, or modifications to corrective measures based on their assessment
• Investigation procedures: Reviews can include on-site inspections, expert consultations, independent testing, and coordination with notified bodies across EU member states
• Ongoing compliance obligations: Manufacturers must respond promptly to requests, implement agreed corrective actions, and provide regular investigation updates
• Broader safety communication: Authorities may require healthcare professional notifications, safety alerts, or market surveillance actions when incidents indicate wider safety concerns

This comprehensive review process ensures that adverse events receive appropriate regulatory attention while supporting continuous improvement in medical device safety. The collaborative approach between manufacturers and authorities helps identify systemic issues and implement effective preventive measures across the European market.

How MedEnvoy Global Helps With European Adverse Event Reporting

MedEnvoy Global provides comprehensive support for manufacturers navigating complex European adverse event reporting requirements, ensuring timely compliance while maintaining focus on product innovation and patient safety. Our expert team streamlines the entire reporting process through:

• EUDAMED submission management: Automated workflows and deadline tracking ensure timely report submission while maintaining quality standards
• Expert regulatory review: Specialized assessment of incident evaluations and authority correspondence to optimize compliance outcomes
• Template development: Standardized reporting formats for consistent, compliant documentation across all severity levels and device types
• Regulatory intelligence: Real-time monitoring of competent authority requirements and regulatory updates affecting reporting obligations
• Training and capacity building: Comprehensive programs for internal teams covering incident identification, assessment, and response protocols
• Post-submission support: Ongoing assistance with authority communications, follow-up reporting, and corrective action implementation

Our integrated approach combines technical expertise with practical experience to help manufacturers build robust adverse event reporting systems that support both regulatory compliance and continuous safety improvement. This comprehensive support enables companies to focus on innovation while maintaining the highest standards of patient safety and regulatory excellence.

Ready to strengthen your European adverse event reporting capabilities? Contact MedEnvoy Global today to learn how our specialized regulatory expertise can help you maintain compliance while protecting patient safety and supporting your business objectives.

Related Articles

• Are European Medical Device Requirements Different From the US?
• Do I Need a Representative to Sell in Europe?
• How much does Swissdamed registration cost?
• Can You Use a Scoring Model to Rank Market Entry Opportunities?
• What Is the Mexican Medical Device Classification System?